| Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA) M Sartelli, DG Weber, E Ruppé, M Bassetti, BJ Wright, L Ansaloni, ... World journal of emergency surgery 11, 1-32, 2016 | 240 | 2016 |
| Carbapenem resistance in Acinetobacter baumannii: laboratory challenges, mechanistic insights and therapeutic strategies I Abbott, GM Cerqueira, S Bhuiyan, AY Peleg Expert review of anti-infective therapy 11 (4), 395-409, 2013 | 223 | 2013 |
| Nitrofurantoin and fosfomycin for resistant urinary tract infections: old drugs for emerging problems BJ Gardiner, AJ Stewardson, IJ Abbott, AY Peleg Australian prescriber 42 (1), 14, 2019 | 176 | 2019 |
| Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment IJ Abbott, MA Slavin, JD Turnidge, KA Thursky, LJ Worth Expert review of anti-infective therapy 9 (4), 471-488, 2011 | 156 | 2011 |
| Stenotrophomonas, Achromobacter, and nonmelioid Burkholderia species: antimicrobial resistance and therapeutic strategies IJ Abbott, AY Peleg Seminars in respiratory and critical care medicine 36 (01), 099-110, 2015 | 144 | 2015 |
| Prescribing trends before and after implementation of an antimicrobial stewardship program KA Cairns, AWJ Jenney, IJ Abbott, MJ Skinner, JS Doyle, M Dooley, ... Medical Journal of Australia 198 (5), 262-266, 2013 | 74 | 2013 |
| Genomic dissection of Klebsiella pneumoniae infections in hospital patients reveals insights into an opportunistic pathogen CL Gorrie, M Mirčeta, RR Wick, LM Judd, MMC Lam, R Gomi, IJ Abbott, ... Nature communications 13 (1), 3017, 2022 | 73 | 2022 |
| Evolution of daptomycin resistance in coagulase-negative staphylococci involves mutations of the essential two-component regulator WalKR JH Jiang, C Dexter, DR Cameron, IR Monk, SL Baines, IJ Abbott, ... Antimicrobial agents and chemotherapy 63 (3), 10.1128/aac. 01926-18, 2019 | 35 | 2019 |
| Fosfomycin efficacy and emergence of resistance among Enterobacteriaceae in an in vitro dynamic bladder infection model IJ Abbott, J Meletiadis, I Belghanch, RA Wijma, L Kanioura, JA Roberts, ... Journal of Antimicrobial Chemotherapy 73 (3), 709-719, 2018 | 35 | 2018 |
| Lab on a chip sensor for rapid detection and antibiotic resistance determination of Staphylococcus aureus CD Abeyrathne, DH Huynh, TW Mcintire, TC Nguyen, B Nasr, D Zantomio, ... Analyst 141 (6), 1922-1929, 2016 | 35 | 2016 |
| Epstein-Barr virus encephalitis in solid organ transplantation JSY Lau, ZM Low, I Abbott, L Shochet, J Kanellis, AR Kitching, ... New Microbiol 40 (3), 212-217, 2017 | 27 | 2017 |
| Treatment of invasive IMP‐4 Enterobacter cloacae infection in transplant recipients using ceftazidime/avibactam with aztreonam: A case series and literature review KA Cairns, V Hall, GE Martin, DWJ Griffin, JD Stewart, SF Khan, IJ Abbott, ... Transplant Infectious Disease 23 (2), e13510, 2021 | 26 | 2021 |
| Infusional β-lactam antibiotics in febrile neutropenia: has the time come? IJ Abbott, JA Roberts Current Opinion in Infectious Diseases 25 (6), 619-625, 2012 | 23 | 2012 |
| Evaluation of pooled human urine and synthetic alternatives in a dynamic bladder infection in vitro model simulating oral fosfomycin therapy IJ Abbott, E van Gorp, RA Wijma, J Meletiadis, JW Mouton, AY Peleg Journal of microbiological methods 171, 105861, 2020 | 22 | 2020 |
| In vivo acquisition of fosfomycin resistance in Escherichia coli by fosA transmission from commensal flora T Ten Doesschate, IJ Abbott, RJL Willems, J Top, MRC Rogers, ... Journal of Antimicrobial Chemotherapy 74 (12), 3630-3632, 2019 | 22 | 2019 |
| Development and management of systemic lupus erythematosus in an HIV-infected man with hepatitis C and B co-infection following interferon therapy: a case report IJ Abbott, CC Chang, MJ Skinner, A Street, G Perry, C McLean, EJ Wright, ... Journal of Medical Case Reports 3, 1-5, 2009 | 21 | 2009 |
| Oral Fosfomycin Treatment for Enterococcal Urinary Tract Infections in a Dynamic In Vitro Model IJ Abbott, E van Gorp, A van Der Meijden, RA Wijma, J Meletiadis, ... Antimicrobial Agents and Chemotherapy 64 (6), 10.1128/aac. 00342-20, 2020 | 20 | 2020 |
| Reduced In Vitro Activity of Ceftaroline by Etest among Clonal Complex 239 Methicillin-Resistant Staphylococcus aureus Clinical Strains from Australia IJ Abbott, AWJ Jenney, CJ Jeremiah, M Mirčeta, JP Kandiah, DC Holt, ... Antimicrobial agents and chemotherapy 59 (12), 7837-7841, 2015 | 20 | 2015 |
| Genomic surveillance of antimicrobial resistant bacterial colonisation and infection in intensive care patients KL Wyres, J Hawkey, M Mirčeta, LM Judd, RR Wick, CL Gorrie, NF Pratt, ... BMC infectious diseases 21, 1-11, 2021 | 18 | 2021 |
| Impact of bacterial species and baseline resistance on fosfomycin efficacy in urinary tract infections IJ Abbott, J Dekker, E van Gorp, RA Wijma, MN Raaphorst, ... Journal of Antimicrobial Chemotherapy 75 (4), 988-996, 2020 | 17 | 2020 |
